cyclopentane has been researched along with Atrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BERLINGUET, L; DUNNIGAN, J; GAGNON, PM | 1 |
Han, J; Kim, B; Kim, JC; Shin, HC | 1 |
Bonhomme, E; Cody, DB; Dehghani, B; Elenich, LA; Kelly, MJ; Magrisso, IJ; Murphy, SJ; Offner, H; Rick, EA; Rosenbaum, JS; Subramanian, S; Vandenbark, AA; Wang, C | 1 |
3 other study(ies) available for cyclopentane and Atrophy
Article | Year |
---|---|
SELECTIVE EFFECT OF 1-AMINO CYCLOPENTANE CARBOXYLIC ACID ON PANCREATIC ACINAR TISSUE AND ITS PROTEASE ACTIVITY.
Topics: Amino Acids; Atrophy; Body Weight; Carboxylic Acids; Cycloparaffins; Cyclopentanes; Pancreas; Pathology; Peptide Hydrolases; Rats; Research; Toxicology | 1964 |
Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Topics: Administration, Oral; Animals; Area Under Curve; Atrophy; Body Weight; Cyclopentanes; Dogs; Dose-Response Relationship, Drug; Eating; Female; Hydrazines; Male; Phosphodiesterase Inhibitors; Salivation; Thymus Gland; Toxicity Tests; Vomiting | 2004 |
GPR30 contributes to estrogen-induced thymic atrophy.
Topics: Animals; Apoptosis; Atrophy; Cyclopentanes; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Inbreeding; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Quinolines; Receptors, G-Protein-Coupled; T-Lymphocytes; Thymus Gland | 2008 |